Related Experiment Video
Updated: Aug 7, 2026
07:55
Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
Published on: October 17, 2015
Effect of ischemic neuronal insults on amyloid precursor protein processing
Phil Hyu Lee1, Eun Mi Hwang, Hyun Seok Hong
1Department of Neurology, Ajou University School of Medicine, Woncheon-dong San 5, Suwon, Gyungki-do 442-749, South Korea.
Neurochemical Research
|June 24, 2006
Summary
Ischemic stroke impacts amyloid precursor protein (APP) processing, increasing amyloid-beta (Abeta) production. This study reveals how neuronal insults from ischemia may contribute to Alzheimer
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- The relationship between ischemic stroke and Alzheimer's disease (AD) at the molecular level remains unclear.
- Alzheimer's disease is characterized by the accumulation of amyloid-beta (Abeta) peptides.
- Cerebral ischemia can lead to neuronal damage and dysfunction.
Purpose of the Study:
- To investigate the effects of ischemic neuronal insults on amyloid precursor protein (APP) processing pathways.
- To determine how cerebral ischemia influences the production of Abeta.
- To explore the molecular mechanisms linking ischemic events to AD pathogenesis.
Main Methods:
- Utilized an in vitro model of cerebral ischemia (oxygen-glucose deprivation).
- Examined APP processing in human neuroblastoma cells and primary cultures of Tg2576 transgenic mice expressing human APP.
- Assessed the activity of key enzymes involved in APP metabolism, including ADAM10, BACE, and gamma-secretase.
Main Results:
- Ischemic insults significantly increased Abeta production in Tg2576 primary cultures.
- A disintegrin and metalloprotease 10 (ADAM10) expression showed dynamic changes, increasing early and decreasing later during ischemic insults.
- Gamma-secretase activity was significantly elevated after 4 hours of ischemic insults, while BACE levels and activity remained unchanged.
Conclusions:
- Ischemic neuronal insults alter APP metabolism, leading to increased Abeta production.
- The modulation of APP processing enzymes, particularly gamma-secretase, by ischemia suggests a potential molecular link to Alzheimer's disease.
- These findings highlight a possible mechanism by which cerebrovascular events may contribute to AD pathogenesis.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...